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ABSTRACT
E2F transcription factors (E2F1-8) are known to co-
ordinately regulate the expression of a plethora of
target genes, including those coding for microRNAs
(miRNAs), to control cell cycle progression. Recent
work has described the atypical E2F factor E2F7
as a transcriptional repressor of cell cycle-related
protein-coding genes. However, the contribution of
E2F7 to miRNA gene expression during the cell cy-
cle has not been defined. We have performed a
genome-wide RNA sequencing analysis to identify
E2F7-regulated miRNAs and show that E2F7 plays
as a major role in the negative regulation of a set of
miRNAs that promote cellular proliferation. We pro-
vide mechanistic evidence for an interplay between
E2F7 and the canonical E2F factors E2F1-3 in the
regulation of multiple miRNAs. We show that miR-
25, -26a, -27b, -92a and -7 expression is controlled
at the transcriptional level by the antagonistic ac-
tivity of E2F7 and E2F1-3. By contrast, let-7 miRNA
expression is controlled indirectly through a novel
E2F/c-MYC/LIN28B axis, whereby E2F7 and E2F1-3
modulate c-MYC and LIN28B levels to impact let-7
miRNA processing and maturation. Taken together,
our data uncover a new regulatory network involving
transcriptional and post-transcriptional mechanisms
controlled by E2F7 to restrain cell cycle progression
through repression of proliferation-promoting miR-
NAs.
INTRODUCTION
Since the initial identification of E2F as the cellular factor
required for activation of the E2 adenoviral promoter, the
E2F family of transcription factors has expanded through
the addition of new members in mammals and through the
discovery of homologs in other eukaryotes. Eight mam-
malian E2F family members (E2F1-8) have been identi-
fied, which orchestrate a complex gene regulatory network
to ensure proper cell cycle progression, cellular differentia-
tion and development (1,2). However, it is still unclear what
the precise roles of each individual E2F member are, and
how the activity of the whole E2F family is coordinated to
achieve an integrated regulation of gene expression.
Canonical E2F proteins (E2F1-6) bear one DNA-
binding domain (DBD) immediately followed by a dimer-
ization domain, which mediates interaction with the dimer-
ization partner protein (DP). This dimerization enables
E2Fs to bind DNA with high affinity, and to function as
transcriptional regulators (3). According to the prevailing
model, transcriptional regulation by canonical E2Fs is con-
trolled through association with the retinoblastoma (RB)
family of tumor suppressor proteins (pRB, p107 and p130)
in the case of E2F1-5, or with polycomb group (PcG) pro-
teins, in the case of E2F6 (4). These associations facilitate
recruitment of histone deacetylases and methyltransferases
to target promoters and subsequent transcriptional repres-
sion. Disruption of repressor complexes unleashes E2F ac-
tivity, thereby triggering target gene transcription (3).
By contrast to canonical E2Fs, the atypical members
E2F7 and E2F8, display two tandem DBDs and lack se-
quences that mediate RB and DP binding (5). The mech-
anisms by which atypical E2Fs regulate gene expression
as well as their biological roles are still unclear. Gain-of-
function experiments have revealed that E2F7 and E2F8 are
recruited to promoters of several E2F target genes involved
in DNA replication and DNA repair, and repress E2F site-
dependent transcription in a RB-independent manner (6–
11). Furthermore, overexpression of either E2F7 or E2F8
disrupts cell cycle progression, suggesting that they might
promote negative cell cycle control through transcriptional
repression of cell cycle genes (6–11). However, knockout
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(KO) of E2F7 or E2F8 in mice has no significant effect
on cell cycle progression, and a concomitant inactivation
of E2F7 and E2F8 is needed to impact on cell cycle pro-
gression in vivo (12). This is probably due to compensatory
mechanisms between both E2Fs, a common outcome in
constitutive KO mouse models. Thus, the specific contribu-
tion of E2F7 and E2F8 to cell cycle control remains to be
elucidated.
Significant progress in the understanding of E2F-
mediated regulation of gene expression has been achieved
by the finding that many microRNA-coding genes are bona
fide E2F target genes (13–20). In line with the complex na-
ture of the E2F pathway, many reports have uncovered an
essential role for E2F-regulated microRNAs in modulat-
ing distinct cellular processes, most notably pathways in-
volved in neoplastic transformation (21,22). Some of these
E2F-regulated miRNAs, including miR-17-92, miR-106b-
25, mir-15b-16-2 and miR-15a-16-1, appear to function
as tumor suppressors that modulate and restrict progres-
sion through the cell cycle by limiting the expression of
E2Fs themselves as well as other pathway components,
thereby creating negative feedback loops (14,16,18). By
contrast, there is also evidence for an oncogenic poten-
tial for some E2F-dependent miRNAs. For instance, miR-
17-92 and miR-106b-25 clusters have been found to sup-
press the expression of anti-proliferative and pro-apoptotic
genes, such as p21CIP1, pRB, p130, p57KIP2, PTEN and BIM
(13,17,23–25). Given that each miRNA can regulate the ex-
pression of numerous genes, the list of genes regulated by
miRNAs under E2F control is likely to include other, yet to
be identified, targets.
The contribution of atypical E2F factors to miRNA ex-
pression regulation, and the effect that target miRNAs have
on the biological roles mediated by E2F7 and E2F8, are
still unknown. In this work, we have investigated the role
of E2F7 in the regulation of miRNA-coding gene expres-
sion. We show that E2F7 is required for the timely repres-
sion of a set of miRNAs that function to promote cell prolif-
eration. Importantly, our data uncover both transcriptional
and post-transcriptional mechanisms for E2F7-mediated
regulation of these miRNAs, and provide new insights to
the understanding of E2F-regulated gene network.
MATERIALS AND METHODS
Cell culture conditions and flow cytometry
Human U2OS osteosarcoma cell line and human embry-
onic kidney (HEK) 293T cells were maintained in Dul-
becco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum (FBS). For cell synchronization in G1/S,
exponentially growing cells were incubated with 4 mM hy-
droxyurea (HU) for 24 h and subsequently washed and cul-
tured in complete medium. For cell synchronization at mi-
tosis, cell cultures were incubated with thymidine (2 mM)
for 18 h. Subsequently, cells were washed and cultured for
an additional 20 h in fresh medium. Nocodazole (50 ng/ml)
was added to the cultures for the last 16 h. Mitotic cells were
collected by shaking off the plates and seeded in complete
medium for subsequent analyses. To assess the cell cycle dis-
tribution, cells were fixed with chilled 70% ethanol, stained
with 50 g/ml propidium iodide (PI) and analyzed by flow
cytometry (FACSCalibur, BD). To analyze the percentage
of cells in mitosis, ethanol-fixed cells were stained with an
antibody recognizing Histone H3 phosphorylated on Ser-
ine 10 (p-H3) conjugated with FITC (06-570, Millipore),
subsequently incubated with PI and analyzed by flow cy-
tometry. Cell cycle distribution and mitotix index analysis
was performed with Summit 4.3 software. For cell prolifer-
ation assays, cells were stained with 0.5 M carboxyfluores-
cein diacetate succinimidyl ester (CFSE) (MolecularProbes)
in phosphate buffered saline for 15 min at 37◦C, washed
with complete medium for 20 min and then treated and cul-
tured as indicated. Cells were fixed for 10 min in a solution
of buffered formaldehyde (3.7%) and fluorescence was de-
tected and analyzed by flow cytometry. Proliferation Wiz-
ard software was used to identify cells in different cellular
generations and determine proliferation index, which was
calculated as the sum of the cells in all generations includ-
ing the parental divided by the computed number of origi-
nal parent cells present at the start of the experiment.
Transfections
Plasmid transfection was performed using XtremeGENE
HD (Roche) transfection reagent following manufac-
turer´s recommendations. Mammalian expression plasmids
pRc-CMV-HA-E2F1, pRc-CMV-HA-E2F2, pRc-CMV-
HA-E2F3, pCEFL-MYC and pFRT/FLAG/HA-DEST-
LIN28B have been previously described (26–28). For ex-
ogenous expression of miRNAs, miRNA genes were ex-
pressed in the pMirVec vector (29). To silence endoge-
nous expression of E2F1, E2F2, E2F3, E2F7, c-MYC and
LIN28B, and to inhibit endogenous microRNA activity,
cells were transfected with commercial siRNAs and with
miRVana microRNA Inhibitors, respectively (Life Tech-
nologies), at a final concentration of 10 nM using Lipofec-
tamine RNAiMAX (Life Technologies) following manufac-
turer’s recommendations.
RNA expression analyses
Total RNA extraction was performed with TRIzol Reagent
(Life Technologies) and purified using the miRNeasy kit
(Qiagen) following the manufacturer’s recommendations.
For small RNA-Sequencing (RNA-Seq), 2 g of total
RNA containing the small RNA fraction including miR-
NAs was processed using the TruSeq Small RNA Sam-
ple Preparation kit from Illumina. The resulting libraries
were sequenced on the Genome Analyzer IIx with SBS
TruSeq v5 reagents following manufacturer’s protocols. To
test for differential miRNA expression between different
samples the Bioconductor DESeq package was used (30).
The list of differentially expressed miRNAs produced by
DESeq was further filtered to remove miRNAs with fewer
than 10 reads in the different samples under comparison
(31). Clustering analysis of differentially expressed miR-
NAs was performed with Perseus software (http://www.
perseus-framework.org/).
Predicted targets of microRNAs were identified using
the DIANA-microT-CDS miRNA target prediction server
(32) and then analyzed for pathway enrichment using terms
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< 0.001) to avoid inconsistent results due to the use of dif-
ferent databases or algorithms, as suggested previously (34).
Gene ontology analysis was performed using the FatiScan
algorithm (35).
Mature microRNA and Primary microRNA (Pri-
miRNA) RT-Q-PCR analyses were performed using
specific TaqMan microRNA and Pri-miRNA assays,
respectively (Life Technologies) (Supplementary Table
S1). For mRNA expression analysis, RNA was reverse-
transcribed into cDNA with the High-Capacity cDNA
RT Kit (Life Technologies) and Q-PCR was performed as
described previously (36). Sequences of Q-PCR primers
are listed in Supplementary Table S2.
Protein expression analyses
For western blot analyses, cells were lysed in buffer con-
taining 10 mM NaH2PO4 pH 7.2; 1 mM EDTA; 1
mM EGTA; 150 mM NaCl; 1% NP-40 and a cock-
tail of protease and phosphatase inhibitors (Roche). Pro-
tein concentrations in supernatants were determined us-
ing a commercially available kit (DC Protein Assay from
Bio-Rad). A total of 20 g of protein were loaded per
lane, fractionated in 8–10% sodium dodecyl sulphate-
polyacrylamide gels and transferred onto nitrocellulose
membranes (Bio-Rad). Antibodies against the following
proteins were used: E2F7 (sc-32574, Santa Cruz), Cyclin E1
(4129, Cell Signaling), c-MYC (sc-42, Santa Cruz), LIN28B
(4192, Cell Signaling), HA (MMS-101R, Covance), p-H3
(06-570, Millipore), -Tubulin (T-9026, Sigma), -Actin
(A5441, Sigma). Immunocomplexes were visualized with
horseradish peroxidase-conjugated anti-mouse, anti-goat
or anti-rabbit IgG antibodies (Santa Cruz), followed by
chemiluminiscence detection (ECL, Amersham) with a
ChemiDoc camera (Bio-Rad).
Chromatin immunoprecipitation
Chromatin immunoprecipitations (ChIPs) and the quantifi-
cation of immunoprecipitated DNA sequences by Q-PCR
were performed as described previously (36). The localiza-
tion of E2F motifs in E2F7-regulated miRNAs was carried
out with the MotifLocator tool of the TOUCAN program
(37). The search was restricted to the proximal promoter re-
gion (−1000 and +500 bp relative to the transcription start
site) (38). Sequences of Q-PCR primers are listed in Supple-
mentary Table S3. Antibodies used for ChIP analysis were:
E2F1 (sc-193, Santa Cruz), E2F2 (sc-633, Santa Cruz),
E2F3 (sc-878, Santa Cruz), E2F4 (sc-1082, Santa Cruz),
E2F7 (sc-66870, Santa Cruz), RB (sc-50 Santa Cruz), p107
(sc-318 Santa Cruz), p130 (sc-317 Santa Cruz), MYC (sc-
764 Santa Cruz), RNA polymerase II (sc-899, Santa Cruz)
and SV40LT (sc-147, Santa Cruz).
Statistical analysis
Data are presented as mean ± SD. The significance of the
difference between two groups was assessed using the Stu-
dent two-tailed t-test. A P < 0.05 was considered statisti-
cally significant.
RESULTS
Acute loss of E2F7 accelerates cell cycle progression
E2F7 gene expression is regulated in a cell cycle-dependent
manner in U2OS cells, with reduced levels at M and G1
phases and a peak expression in G1/S transition and S
phase (Supplementary Figure S1 A and B), consistent with
previous reports (11). We assessed whether E2F7 is re-
quired for timely cell cycle progression by acutely deplet-
ing E2F7 and examining cell cycle distribution over time.
Endogenous E2F7 was depleted very efficiently in U2OS
cells individually transfected with three independent RNAi
molecules specific for E2F7 (siE2F7), but not in cells trans-
fected with an oligonucleotide whose sequence has no speci-
ficity to any human protein (siNT) used as a control (Fig-
ure 1A and Supplementary Figure S2). Importantly, E2F7
depletion resulted in substantially increased mRNA levels
of known E2F7-downregulated genes (E2F1, E2F2, E2F3
and Cyclin E1), confirming loss of E2F7-mediated repres-
sion in siE2F7-transfected cells (Figure 1A and Supplemen-
tary Figure S2).
To monitor cell cycle progression upon acute silencing of
E2F7, U2OS cells were HU-synchronized at G1/S bound-
ary and subsequently transfected with E2F7-specific siR-
NAs. Upon removal of the drug, cells were harvested every
3 h for FACS analyses (Figure 1B). DNA content analyses
revealed a comparable block in G1/S in non-target control
and E2F7 siRNA transfected cells. Remarkably, upon HU
release, entry into S-phase in E2F7-depleted cells was signif-
icantly accelerated compared to control cells. This effect was
visible as early as 3 h after HU release (48% in siE2F7 versus
40% siNT). Likewise, E2F7 depleted cells showed an ear-
lier entry into G2 phase 6 h after exiting from HU-induced
block (41 versus 27%) and it was also evident at the 9 h
time point (67 versus 52%). Similarly, E2F7 depleted cells
synchronized in M-phase with nocodazole showed acceler-
ated entry and progression into S phase as well as into G2
(50% in siE2F7 versus 39% siNT at the 15 h-time-point fol-
lowing exit from mitotic arrest) in comparison with control
siRNA transfected cells (Supplementary Figure S3). Con-
sistent with these results, E2F7 siRNA transfected cells ex-
hibited earlier and increased levels of the mitotic marker p-
H3 after cell cycle re-entry from a HU-induced block (Fig-
ure 1C). By contrast, E2F8 depletion in U2OS cells did not
result in a significant impact on cell cycle progression, even
though E2F7 and E2F8 showed similar expression levels in
U2OS cells (Supplementary Figure S4).
In parallel, we examined the rate of cell proliferation by
labeling the cells with the vital fluorescent dye CFSE, which
is diluted ∼2-fold with each cell division. Consistent with
cell cycle analyses, E2F7-depleted cells displayed a higher
proliferation rate compared to siNT cells (Figure 1D). Thus,
by inducing acute loss of E2F7, our data reveal that E2F7 is
indispensable for correct progression through the cell cycle
and for cellular proliferation, and that this role is not satis-
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Figure 1. Accelerated cell cycle progression and increased proliferation in cells lacking E2F7. (A) RT-Q-PCR analyses of E2F1, E2F2, E2F3 and Cyclin E1
(CCNE1) in cells treated with siE2F7 #1 or a non-target siRNA (siNT) for 12 h. Western blot analysis shows efficient depletion of E2F7 by transfection
of specific siRNA molecules. mRNA expression values are normalized to the expression of EIF2C2, used as a standard control. Results are expressed
as fold over siNT values (mean ± SD) from three independent experiments. (B) U2OS cells were treated with 4 mM HU and 12 h later were transfected
with NT siRNA and E2F7 siRNA (#1). Cells were washed after 24 h of HU treatment, harvested every 3 h and processed for FACS analysis. Shown
is the experimental design followed. The percentage of cells in G1 (green), S (red) and G2/M (blue) ± SEM (standard error of the mean) is indicated
and correspond to the average of three independent replicates. (C) Lysates from cells treated as in panel B, harvested at indicated times after HU release
were used for western blot analyses of p-H3 (Ser 10). (D) Proliferation of representative siNT and siE2F7 transfected cultures. U2OS cells were incubated
with CFSE, transfected with indicated siRNAs and cultured for 24 h. Proliferation Index (PI) corresponds to the average of three experiments. Shown are
representative images of the parental population (P) and the proliferative cellular generations in each condition (indicated with numbers). Asterisks (*)
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Identification of E2F7-regulated miRNAs
We set out to identify microRNAs that could contribute to
E2F7-mediated cell cycle and proliferation control. To this
end, unbiased RNA-Seq experiments were conducted using
RNA derived from E2F7-competent and E2F7-depleted
cells at G1/S transition (0 h), S phase (3 h) and G2/M
boundary (12 h) of cell cycle following exit from HU-
induced block. The expression level of endogenous E2F7
was appreciable in all three time-points (Supplementary
Figure S1B). Three independent RNA-Seq experiments
were performed for each condition (siE2F7 versus siNT)
and time-point. Close to 1100 miRNAs were identified in
the three time-points analyzed. A list of differentially ex-
pressed miRNAs between control and E2F7-depleted cells
was produced by Bioconductor DESeq package (30) and
only those miRNAs with fold-changes higher than 1.5
(siE2F7 versus siNT) in at least two of the three experiments
were considered. Using these criteria a total of 18 miR-
NAs were found to be consistently deregulated upon E2F7
knockdown (Figure 2A and Supplementary Table S4), 15 of
which were upregulated in at least two time-points of the cell
cycle. These data suggest a major role for E2F7 as a negative
regulator of miRNA expression throughout the cell cycle.
Within the set of E2F7-regulated miRNAs, miR-25, let-
7f and miR-92a have been previously identified as E2F1
and E2F3 targets (14,17–19,39). Of note, whereas E2F1 and
E2F3 are known to induce the expression of these miR-
NAs, our data indicate that E2F7 represses their expres-
sion. In addition, our deep-sequencing analyses produced
many other miRNAs that represent potentially novel E2F-
regulated miRNAs (Figure 2A and Supplementary Table
S4). E2F7 has been reported to repress E2F site-dependent
transcription (7,8,11). To identify potential E2F motifs
within E2F7-represed microRNAs, we made use of the Mo-
tifLocator tool provided by TOUCAN program (37). Using
a threshold level of 0.8 for similarity with the canonical E2F
motif recorded in the TRANSFAC database, we found that
67% of E2F7-repressed genes harbored at least one canoni-
cal E2F motif within the −1000/+500 bp regulatory region
(Supplementary Table S5).
From the collection of miRNAs that were differentially
expressed in E2F7-depleted cells, we selected those that
have been previously related with E2F (miR-25, let-7f and
miR-92a) as well as a set of miRNAs bearing E2F mo-
tifs in their promoter regions (let-7b, miR-26a, miR-27b
and miR-7) (Supplementary Table S5) for further analyses.
Conventional RT-Q-PCR assays of the selected miRNAs
showed significantly increased expression levels upon E2F7
knockdown in the three cell cycle phases analyzed (Figure
2B), thus validating the small RNA-Seq experiment results.
We subsequently examined potential pathways regulated by
these miRNAs by performing a bioinformatics analysis of
their predicted targets. Interestingly, Gene Ontology anal-
ysis of the combined predicted targets revealed that E2F7-
repressed miRNAs preferentially modulate genes involved
in cell cycle and mitotic regulation (Figure 2C). Other bio-
logical processes including hemostasis, signaling by Nerve
Growth Factor (NGF) or transmembrane transport also
appeared enriched in this analysis, suggesting that E2F7
regulates a diversity of functions through control of mi-
croRNA expression.
E2F7-repressed miRNAs modulate cell proliferation
We tested whether miRNAs repressed by E2F7 (miR-
25, let-7f, let-7b, miR-26a, miR-27b, miR-92a and miR-
7) could contribute to E2F7-dependent control of the cell
cycle. U2OS cells were transfected with expression vectors
coding for these miRNAs, and cell cycle distribution pro-
files were analyzed. Ectopic expression of individual miR-
NAs gave rise to a slight acceleration of the first cell division
cycle relative to scramble control-transfected cells (Supple-
mentary Figures S5, S6 and data not shown). Importantly,
this effect was amplified after several cell division cycles,
and we observed significantly increased proliferation rates
when fluorescence of CFSE-stained cells was quantified af-
ter overexpression of individual miRNAs (Figure 3A and
Supplementary Table S6). Furthermore, blocking endoge-
nous miRNA activity with a pool of anti-miRNA oligonu-
cleotides reversed the accelerated cell cycle progression in-
duced by E2F7 knockdown (Supplementary Figure S7).
We next assessed whether E2F7-regulated miRNAs could
promote cell proliferation by limiting the expression of
miRNA target genes involved in cell growth inhibition. Sev-
eral critical cell cycle inhibitors reported to be regulated by
these miRNAs, such as p21Cip1, p57Kip2, PTEN and p130,
were indeed downregulated in U2OS cells overexpressing
individual E2F7-repressed miRNAs (Figure 3B). p18INK4C,
which has not been reported to be regulated by microRNAs,
showed no differences in this assay, ruling out possible gen-
eral effects due to an overall proliferation increase. Collec-
tively, these results point to a role for these microRNAs in
E2F7-mediated negative regulation of cell proliferation and
cell cycle control by modulating the levels of critical cell cy-
cle inhibitors.
E2F factors are bound to the promoter region of miR-25,
miR-26a, miR-27b, miR-92a and miR-7
To begin to dissect the mechanism by which E2F7 represses
the expression of miRNAs during the cell cycle, we exam-
ined binding of E2F7 to the regulatory regions of the val-
idated miRNAs. Binding of E2F7 was examined by ChIP
analyses followed by Q-PCR with specific oligonucleotides
for each miRNA regulatory region bearing E2F consen-
sus sites (Figure 4A). The regulatory region of let-7f lacks
putative E2F binding sites, and was therefore discarded
for binding studies. The -actin gene (ACTB), whose pro-
moter lacks active E2F sites (36), was used as a negative
promoter control. We made use of chromatin derived from
cells collected at 3 h following HU release (corresponding
to S-phase cells). Additionally, as a control for non-specific
ChIP, parallel ChIP assays were carried out with an irrel-
evant antibody (SV40LT). As shown in Figure 4B, ChIP
analyses revealed robust E2F7 binding to the regulatory re-
gion of miR-25, miR-92a and miR-7 (compare binding to
ACTB), suggesting that E2F7 represses miR-25, miR-92a
and miR-7 expression by directly binding to their regulatory
region. By contrast, we did not to detect binding of E2F7
to the regulatory regions of miR-26a, miR-27b and let-7b,
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Figure 2. Identification of E2F7-regulated miRNAs by small RNA-Seq analysis. (A) MicroRNA expression profiles in siE2F7#1 transfected cells at various
time-points after HU release. Data are normalized to the levels of siNT-treated cells. Red indicates upregulation and blue indicates downregulation. (B)
Confirmatory RT-Q-PCR expression analyses in E2F7-depleted cells at various time-points after HU release. Mature miR-25, let-7f, let-7b, miR-26a,
miR-27b, miR-92a and miR-7 expression levels were analyzed and normalized to RNU6B and RNU19 levels. Data are represented as fold-change relative
to siNT-transfected samples (*P < 0.05). (C) Gene ontology (GO) analysis of predicted targets of E2F7-repressed miRNAs using FatiGO tool. Only terms
with adjusted P-value of > 0.001 were considered.
It has been shown that individual E2F target promot-
ers are bound by multiple E2Fs in vivo (36,40). Therefore,
we tested whether other E2F family members could oc-
cupy the regulatory regions of these miRNAs. We focused
on E2F1, E2F2 and E2F3 because they are regulated by
E2F7 (Figure 1A), and thus, could potentially be involved
in E2F7-dependent miRNA regulation. As shown in Figure
4C, we found that E2F1, E2F2 and E2F3 were efficiently
recruited to the promoter region of miR-25 and miR-92a
(>2-fold over -actin promoter amplification), supporting
previous data (14,18,19). Interestingly, miR-26a regulatory
region was bound by E2F3, and both, E2F1 and E2F3,
occupied miR-27b and miR-7 promoters. None of them
was significantly recruited to let-7b. Remarkably, E2F7 de-
pletion led to a dramatic increase in recruitment of E2F1,
E2F2 and E2F3 to miR-25, miR-26a, miR-27b, miR-92a
and miR-7 promoters (Figure 4C, note scale difference),
consistent with the increased expression of these E2Fs in
E2F7-knockdown cells (Figure 1A). Moreover, ectopic ex-
pression of E2F1-3 factors led to an induction of E2F7-
regulated miRNAs (Supplementary Figure S8). These re-
sults point to a direct role for E2F1, E2F2 and E2F3 in the
transcriptional activation of E2F7-repressed miRNAs.
E2F7 regulates let-7 microRNA maturation
The absence of consensus E2F motifs in let-7f regulatory
region and the lack of binding of E2F factors to let-7b,
points to an indirect mechanism for E2F7 in the regula-
tion of these miRNAs. We examined the abundance of let-
7f and let-7b immature primary transcripts in U2OS cells
transfected with non-target or E2F7-specific siRNAs. We
included miR-25 in our assay as a control of a miRNA
whose promoter is bound by E2F7 (Figure 4B). Unpro-
cessed pri-miR-25 levels were increased in E2F7-depleted
cells (Figure 5A), demonstrating that E2F7 regulates miR-
25 expression at the transcriptional level. By contrast, pri-
let-7f and pri-let-7b levels remained unaffected upon E2F7
knockdown. These findings rule out a transcriptional regu-
lation of let-7f and let-7b by E2F7 and point to a role of this
E2F factor in the maturation pathway of let-7 miRNAs.
The RNA binding proteins LIN28A and LIN28B have
been reported to directly bind to let-7 precursor miRNA
molecules and inhibit their processing into mature and
functional miRNAs (41–45). We tested whether E2F7 de-
pletion had an effect on LIN28 expression. Interestingly,
RT-Q-PCR and western blot analyses showed a substantial
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Figure 3. E2F7-regulated miRNAs target critical cell cycle regulators and enhance cell proliferation. (A) U2OS cells were transfected with various miRNA-
coding plasmids and incubated with CFSE. A vector coding a scramble sequence (scr) was used as a negative control. Cells were harvested 24, 48 and 72
h after transfection and CFSE fluorescence was determined by flow cytometry. Shown are representative images of the distribution of cellular generations
48 h after transfection (indicated with numbers). (B) p21CIP1, p57KIP2, PTEN, p130 and p18INK4C mRNA levels were assessed by RT-Q-PCR in RNA
samples extracted from cells treated as in panel A. Data are represented as normalized log2-ratios over control scr transfection.
ternatively spliced forms) upon E2F7 knockdown (Figure
5B). LIN28A levels were not detected in U2OS cells (data
not shown).
We next assessed whether LIN28B was required for
downregulation of let-7b and let-7f in cell cycle synchro-
nized U2OS cells. Knockdown of LIN28B by RNAi led
to an increased expression of endogenous let-7b and let-7f
(Figure 5C). Conversely, ectopic LIN28B expression abol-
ished the increased expression levels exhibited by let-7f and
let-7b in cells lacking E2F7, but not the levels of miR-
25 (Figure 5D). Collectively, these results imply a post-
transcriptional pathway regulated by E2F7 and LIN28B in
dictating the levels of let-7 miRNAs.
E2F7 regulation of let-7 involves the LIN28/c-MYC axis
LIN28B expression has not been previously linked to E2F.
Instead, LIN28B expression is known to be induced by c-
MYC (46). In addition to the c-MYC binding site previ-
ously reported (46), inspection of LIN28B promoter region
revealed three putative E2F-recognition sites near the tran-
scription start site (Figure 6A). However, ChIP analyses did
not detect endogenous E2F7 bound to LIN28B promoter.
Likewise, E2F1, E2F2 and E2F3 were absent from LIN28B
promoter both in control- and E2F7-depleted cells (Sup-
plementary Figure S9 and data not shown). In contrast,
c-MYC was efficiently recruited to the promoter region
of LIN28B (Figure 6A), and subsequent functional anal-
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Figure 4. E2F factors are recruited to the promoter region of multiple microRNAs. (A) Schematic representation of human miR-25, let-7b, miR-26a, miR-
27b, miR-92a and miR-7 loci within the human MCM7, MIRLET7BHG, CTDSPL, C9ORF3, MIR17HG and HRNPK transcription units, respectively.
The predicted E2F recognition sites are indicated by small filled boxes. Horizontal lines depict the chromatin sequences amplified by Q-PCR. (B) ChIP-
Q-PCR analyses of E2F7-regulated miRNAs. Cell lysates were harvested 3 h after HU release and used for ChIP assays with an antibody against E2F7.
Promoter regions near E2F consensus sites were amplified by Q-PCR. The promoter of -Actin (ACTB) was used as a negative control. An unrelated
antibody against the SV40 large T antigen (SV40LT) was used as a control for background immunoprecipitation. Data are presented as percentage of input
chromatin (representative experiment of three independent experiments where the values are the mean ± SD of triplicate determinations). (C) Cell lysates
from siNT and siE2F7-transfected cells were harvested 3 h after HU release and used for ChIP assays with antibodies against E2F1, E2F2 and E2F3. Note
the Y-axis scale difference in the siE2F7-treated samples. ACTB amplification values are represented as dotted horizontal lines.
LIN28B mRNA and protein levels (Figure 6B), suggesting
that c-MYC directly transactivates LIN28B expression in
U2OS cells.
Importantly, ectopic expression of c-MYC impaired the
reduction of LIN28B expression in E2F7-depleted cells,
and led to a recovery of LIN28B levels close to those in
siNT-treated cells (Figure 6C), suggesting that E2F7 could
control LIN28B expression indirectly through the modula-
tion of c-MYC levels. Furthermore, let-7b upregulation in
siE2F7 treated cells was partially reversed upon c-MYC ex-
pression, whereas miR-25 expression was not negatively af-
fected by c-MYC (Figure 6D).
The above results raised the possibility that E2F7 may
control let-7 and LIN28B expression through c-MYC. In-
deed, we found that c-MYC expression was significantly de-










enter user on 10 July 2019
Nucleic Acids Research, 2016, Vol. 44, No. 12 5565
Figure 5. E2F7 controls let-7f and let-7b maturation through LIN28B (A) E2F7 does not regulate let-7f and let-7b transcription. HU-synchronized cells
were transfected with siNT and siE2F7 and RNA was purified 3 h after cell cycle re-entry. Expression analyses of the indicated pri-miRNAs were performed
using specific Taqman assays. (B) LIN28B expression was analyzed by RT-Q-PCR in cells transfected with siNT or siE2F7 RNAs. mRNA expression values
are normalized to the expression of EIF2C2, used as a standard control. Western blot analysis shows significant downregulation of LIN28B expression
after E2F7 depletion. Specific bands corresponding to two isoforms of LIN28B are indicated with arrows. A non-specific band is indicated with an asterisk.
(C) LIN28B controls let-7f and let-7b expression in U2OS cells. U2OS cells were synchronized in mitosis by nocodazole treatment and transfected with
LIN28B siRNA molecules. RT-Q-PCR analyses of let-7f and let-7b were carried out with RNA samples after 6 h of mitotic block release. Let-7f and let-7b
expression was normalized to RNU6B and RNU19 small RNAs expression, used as standard controls. Data are represented as fold change relative to siNT.
Western blot shows efficient siRNA-mediated knockdown of LIN28B. (D) E2F7 and LIN28B cooperate to regulate let-7f and let-7b expression. let-7f,
let-7b and miR-25 levels were determined in U2OS cells synchronized in mitosis and transfected with E2F7 siRNA together with an expression plasmid
encoding LIN28B (pFRT-LIN28B). Cells were harvested 6 h after block release. miRNA expression levels are shown over the empty transfection. (*P <
0.05 in all graphs). Western blot shows expression of E2F7 and LIN28B in the samples used for miRNA expression analysis. A non-specific band in E2F7
blot is indicated with an asterisk.
pendent siRNA molecules (Figure 6E and Supplementary
Figure S10). This surprising result prompted us to examine
c-MYC regulation in more detail. c-MYC promoter region
has been reported to contain several E2F elements (47),
and our bioinformatic analysis confirmed this point (Figure
7A). However, whether E2Fs are involved in c-MYC regu-
lation has not been clarified. We assessed c-MYC promoter
occupancy by E2F7 as well as by its targets E2F1, E2F2
and E2F3. ChIP analyses revealed robust binding by all
four E2Fs to c-MYC promoter. In addition, E2F7-depleted
cells exhibited dramatically increased promoter binding by
E2F1, E2F2 and E2F3 factors (Figure 7A, note scale dif-
ference), suggesting that E2F7-dependent c-MYC regula-
tion might be mediated, at least in part, by E2F1-3. Ac-
cordingly, c-MYC mRNA and protein levels were increased
upon E2F1, E2F2 and E2F3 depletion (Figure 7B and Sup-
plementary Figure S11A). By contrast, another E2F tar-
get (Cyclin E1) showed decreased expression upon the com-
bined knockdown of E2F1-3 (Figure 7B), as previously re-
ported (48). Moreover, c-MYC expression was negatively
affected by the ectopic expression of E2F1-3, both at the
mRNA and protein levels (Figure 7C and Supplementary
Figure S11B).
Modulation of c-MYC levels by E2F1-3 was not the re-
sult of altered cell-cycle profiles in these cells (Supplemen-
tary Figure S11C) and it did not involve increased pro-
moter binding by classical E2F repressors, such as E2F4,
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Figure 6. E2F7 controls LIN28B expression through c-MYC. (A) Schematic representation of LIN28B promoter region, indicating the localization of
consensus E2F (boxes; −539: TTTCGGGC; −188: GCACGAAA; +177: TTTGGAGC) and c-MYC (triangle; TCCTCGTGCCC) binding motifs. ChIP
analyses were performed with the indicated antibodies and Q-PCR was performed using primers spanning genomic regions around or close to E2F and c-
MYC sites. The horizontal line depicts the chromatin sequence amplified by Q-PCR. Data correspond to a representative experiment of three independent
replicates. (B) RT-Q-PCR and western blot analyses of LIN28B levels in c-MYC depleted cells. Cells blocked in mitosis were transfected with siNT or
siMYC molecules and RNA and protein extracts were harvested 9 h after block release. Western blot shows efficient knockdown of c-MYC in U2OS cells.
mRNA data are shown as fold-change over siNT. (C) RT-Q-PCR analysis of LIN28B mRNA levels in U2OS cells synchronized in mitosis and transfected
with E2F7 siRNA along with an expression plasmid encoding c-MYC (pCEFL-MYC). Cells were harvested 9 h after block release. Data are shown as fold
over the empty vector transfection. Western blot shows c-MYC and E2F7 expression levels in samples used for LIN28B expression analysis. (D) miRNA
levels were assessed in cells treated as in panel C. (E) c-MYC mRNA and protein levels were analyzed in cells synchronized in the cell cycle by HU treatment
and transfected with siNT or siE2F7. mRNA expression values are normalized to the expression of EIF2C2, used as a standard control. (*P < 0.05).
not shown), suggesting that repression of c-MYC by E2F1-
3 could involve RB-independent mechanisms. Consistent
with this, a similar level of c-MYC repression by E2F1-3 was
detected in HEK293T cells (Supplementary Figure S13),
which harbor inactive RB (49).
Importantly, modulation of E2F1-3 levels affected RNA
Pol II occupancy downstream of c-MYC transcription start
site (Figure 7D), which is a measure of c-MYC transcription
rate (50). ChIP data revealed increased association of RNA
Pol II with c-MYC gene in E2F1-3 depleted cells, whereas
RNA Pol II occupancy in Cyclin E1 gene was decreased in
the same experiment. Conversely, ectopic E2F2 expression
negatively impacted on RNA Pol II association to c-MYC
promoter, while Cyclin E1 gene showed an increased occu-
pancy by RNA Pol II in these samples. These results further
demonstrate that E2F1-3 repress c-MYC at the transcrip-
tional level. Thus, we conclude that E2F7 regulates let-7
miRNA expression through a miRNA maturation pathway
involving several intermediate steps controlled by the tran-
scriptional activity of E2F and c-MYC factors.
DISCUSSION
In this work, we have analyzed the contribution of E2F7
transcription factor to the regulation of a subset of novel
target miRNAs during the cell division cycle. We have
discovered transcriptional and post-transcriptional mecha-
nisms by which E2F7 modulates target miRNA expression.
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Figure 7. E2F1, E2F2, E2F3 and E2F7 bind to c-MYC promoter and regulate its expression. (A) Schematic representation of c-MYC promoter region,
indicating the localization of consensus E2F motifs (filled boxes; −977: GCGCCACA; −733: GCAGCAAA; +99: GCGGGAAA; +343: CTTGCCGC).
The horizontal line depicts the ChIP-Q-PCR amplicon. Binding of E2F1, E2F2, E2F3 and E2F7 was assessed by ChIP-Q-PCR in HU-synchronized
cells transfected with E2F7 siRNA or control NT siRNAs. Cell lysates of siNT and siE2F7 treated cells were harvested 3 h after HU release. Note scale
difference between siNT and siE2F7. Dotted horizontal lines represent ACTB amplification values. Data correspond to a representative experiment of
three independent replicates. (B) c-MYC and CCNE1 expression was analyzed by RT-Q-PCR in cells transfected with siNT or a pool of E2F1, E2F2
and E2F3 specific siRNAs. mRNA data are presented as normalized log2-ratios over siNT transfection. (C) U2OS cells were synchronized in mitosis and
transfected with plasmids expressing HA-tagged E2F1, E2F2 and E2F3. c-MYC and CCNE1 levels were analyzed by RT-Q-PCR in samples harvested 6
h after block release. mRNA data are shown as log2-ratios over the empty pCMV transfection. (D) ChIP analyses of RNA-Pol II binding at downstream
regions (>1 kb) of c-MYC and CCNE1 genes. U2OS cells transfected with E2F1, E2F2 and E2F3 specific siRNAs or pCMV-E2F2-HA were used for ChIP
assays with an antibody against RNA-Pol II. Immunoprecipitated DNA was analyzed by Q-PCR using primers in c-MYC and CCNE1 +1 kb region. Data
correspond to a representative experiment of three independent replicates.
of a set of miRNA genes throughout the cell cycle, which in
turn may finely tune pathways controlling cell proliferation.
The role of E2F7 in cell cycle progression has not been
clearly established. Early overexpression experiments sug-
gested that E2F7 could be a negative regulator of the cell cy-
cle (7,8). However, chronic ablation of E2F7 did not impact
cellular proliferation (12). By inducing acute depletion of
E2F7, and thus largely avoiding compensatory mechanisms
that are common after chronic ablation, our data clearly es-
tablish a unique requirement for E2F7 in dictating proper
cell cycle kinetics, a role that is not shared with E2F8 in
U2OS cells. Our observation that E2F7 restrains cell cycle
progression raises the possibility that E2F7 could function
as a tumor suppressor gene, and is consistent with recent
data showing that E2F7 loss together with RB inactivation
promotes oncogenic transformation of murine cells (51).
E2F7 has been shown to repress a set of protein-coding
genes involved in DNA replication and metabolism (11).
The miRNA expression profiling analysis performed in the
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E2F7 function, by providing evidence that this factor has
a major role as a negative regulator of miRNA expression.
miR-25 and let-7f exhibited the highest levels of overexpres-
sion upon E2F7 loss. Interestingly, these miRNAs have pre-
viously been identified as induced by E2F1 and E2F3 in S
phase entry (14), indicating that E2F7 might repress the ex-
pression of miRNAs activated by canonical E2Fs. Other
miRNAs previously related to E2F, such as miR-449a/b
and miR-15 (15,16,20), were not detected in our work, per-
haps because of the restrictive criteria that we used in the
different steps of RNA-Seq data analysis. On the other
hand, our small RNA-Seq experiment has revealed many
other differentially expressed miRNAs that have not been
previously linked to E2F activity, and thus represent poten-
tially novel E2F-regulated miRNAs.
Several of the miRNAs that we found to be repressed by
E2F7 have previously been described as regulators of pro-
liferation pathways (13,14,17,23,24,52–59). However, their
potential roles in cancer have not been clearly established,
as these miRNAs appear to have both oncogenic and anti-
oncogenic functions in different cellular contexts. Our data
evidence that miR-25, let-7f, miR-27b, let-7b, miR-92a,
miR-7 and to a lesser extent miR-26a, promote cell prolif-
eration in U2OS cells, at least in part by silencing the ex-
pression of anti-proliferative cell cycle regulators. Thus, by
downregulating miRNA expression, E2F7 would indirectly
upregulate the levels of cell cycle inhibitors to restrain cell
cycle progression. These findings suggest that E2F7 controls
cell cycle progression and cellular proliferation through a
coordinated performance of both protein-coding and non-
coding genes.
According to our promoter occupancy analyses, the chro-
matin binding properties of E2F7 and canonical E2F fac-
tors in the regulation of target genes appear to be different.
The finding that E2F7 is only bound to E2F sites present
in miR-25, miR-92a, miR-7 and c-MYC, suggests that the
affinity of E2F7 for its binding site could be more restricted
than that of canonical E2F1-3 factors. The basis for this se-
lectivity remains unknown, and could involve unique inter-
actions between E2F7 and other transcription factors at a
particular promoter, as it has been proposed for other mem-
bers of the E2F family (60).
miRNA biogenesis is thought to be regulated at multi-
ple levels through mechanisms that are still not well un-
derstood. Our work reveals that regulation of let-7f and
let-7b maturation by E2F7 involves both transcriptional
and post-transcriptional mechanisms mediated by c-MYC
and LIN28B, adding a new level of complexity to E2F-
mediated miRNA regulation. The mechanism by which
E2F7 modulates c-MYC expression is presently unknown,
although our findings suggest that it involves negative reg-
ulation of E2F1-3 and RNA Pol II activities. Interestingly,
an interplay between E2F7 and c-MYC activity has recently
been suggested (61). Interfering with E2F7 expression re-
sulted in inhibition of c-MYC functional activity in acute
myeloid leukemia (AML) cells by an unknown mechanism.
However, the authors did not report changes in c-MYC or
LIN28B expression. It would be interesting to examine if
E2F7 regulates c-MYC gene expression in AML cells, sim-
ilarly to what we have observed in U2OS cells, and inquire
Figure 8. Model summarizing the mechanism of action of E2F factors,
c-MYC and LIN28B in miRNA expression regulation described in this
study.
into the biological relevance of this novel E2F7-c-MYC-
LIN28B axis in AML cells.
Overall, our study identifies E2F7 as a critical regula-
tor of miRNA biogenesis throughout the cell cycle (Figure
8). Interestingly, we have uncovered a novel interplay be-
tween E2F7 and E2F1-3 in the regulation of miRNAs to
ensure induction and repression of miRNA genes during
the cell division cycle, which in turn could contribute to cell
growth control. In this regard, E2F7 might repress miRNA
gene expression through multiple mechanisms: by binding
to its target genes and directly repressing their transcription
(miR-25, miR-92a and miR-7); by repressing the expression
of E2F1-3, and indirectly suppressing miRNA expression at
the level of transcription (miR-25, miR-26a, miR-27b) or
maturation (let-7b, let-7f); or probably by a combination of
both mechanisms. These findings support a model in which
the transcriptional activity of E2F-target miRNAs may be
dictated by an ‘E2F-network’ in which E2F1-3 and E2F7
play antagonistic roles. A similar mechanism may also be
operating in E2F7-mediated regulation of protein-coding
genes. Future studies may help to further identify the com-
ponents of this novel molecular network as well as its bio-
logical relevance.
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Supplementary Data are available at NAR Online.
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